Operating Lease, Right-of-Use Asset of ImageneBio, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ImageneBio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • ImageneBio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $790,000, a 44% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ImageneBio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $790,000 +$243,000 +44% 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q3 2025 $884,000 -$3,276,000 -79% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $2,561,000 -$2,218,000 -46% 30 Jun 2025 10-Q 24 Jul 2025 2025 Q2
Q1 2025 $3,102,000 -$2,139,000 -41% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $547,000 -$5,139,000 -90% 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q3 2024 $4,160,000 -$3,833,000 -48% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $4,779,000 +$204,000 +4.5% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $5,241,000 +$323,000 +6.6% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $5,686,000 +$431,000 +8.2% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $7,993,000 +$2,408,000 +43% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $4,575,000 -$1,335,000 -23% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $4,918,000 -$1,308,000 -21% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $5,255,000 -$1,283,000 -20% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $5,585,000 -$1,258,000 -18% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $5,910,000 -$1,233,000 -17% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $6,226,000 -$1,212,000 -16% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $6,538,000 +$6,368,000 +3746% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 $6,843,000 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $7,143,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $7,438,000 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $170,000 31 Dec 2020 10-K 17 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.